Advanced intrahepatic cholangiocarcinoma in hepatitis C virus-related decompensated cirrhosis: Case report and review of the literature

European Journal of Gastroenterology and Hepatology

Volumn 15, Issue 3, 2003, Pages 331-334

  Polizos, Asterios ^a   Kelekis, Nikolaos ^a   Sinani, Chrisanthi ^a   Patsiaoura, Kalliopi ^b   Papadamou, Georgia ^a   Dalekos, Georgios N ^a  

^a UNIVERSITY OF THESSALY   (Greece)

^b Ippokration Hospital Thessaloniki   (Greece)

Author keywords

Cholangiocarcinoma; Cirrhosis; Hepatitis C virus

Indexed keywords

ALPHA FETOPROTEIN; AMINOTRANSFERASE; BILIRUBIN; CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; PROTHROMBIN;

ABDOMINAL PAIN; AGED; ARTICLE; BACKACHE; BILE DUCT CARCINOMA; CASE REPORT; CHOLESTASIS; CLINICAL FEATURE; CRYOGLOBULINEMIA; DISEASE ASSOCIATION; DISEASE COURSE; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; HYPERGAMMAGLOBULINEMIA; LIVER CELL CARCINOMA; LIVER CIRRHOSIS; LIVER TUMOR; MALE; PATHOGENESIS; PHYSICAL EXAMINATION; PLEURA EFFUSION; PRIORITY JOURNAL; PROTHROMBIN TIME; SPIRAL COMPUTER ASSISTED TOMOGRAPHY; TREATMENT PLANNING; VIRUS HEPATITIS;

AGED; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; HEPATITIS C, CHRONIC; HUMANS; LIVER CIRRHOSIS; MALE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0344406059     PISSN: 0954691X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042737-200303000-00019     Document Type: Article

References (24)

1. Shimonishi T, Sasaki M, Nakanuma Y. Precancerous lesions of intrahepatic cholangiocarcinoma. J Hepatobiliary Pancreat Surg 2000; 7:542-550.
2. Ahrendt SA, Nakeeb A, Pitt HA. Cholangiocarcinoma. Clin Liver Dis 2001; 5:191-218.
3. Tomimatsu M, Ishiguro N, Taniai M, Okuda H, Saito A, Obata H, et al. Hepatitis C virus antibody in patients with primary liver cancer (hepatocellular carcinoma, cholangiocarcinoma, and combined hepatocellular-cholangiocarcinoma). Cancer 1993; 72:683-688.
4. Yin F, Chen B. Detection of hepatitis C virus RNA sequences in hepatic portal cholangiocarcinoma tissue by reverse transcription polymerase chain reaction. Chin Med J (Engl) 1998; 111:1068-1070.
5. Kobayashi M, Ikeda K, Saitoh S, Suzuki F, Tsubota A, Suzuki Y, et al. Incidence of primary cholangiocellular carcinoma of the liver in Japanese patients with hepatitis C virus-related cirrhosis. Cancer 2000; 88:2471-2477.
6. Yamamoto M, Takasaki K, Nakano M, Saito A. Minute nodular intrahepatic cholangiocarcinoma. Cancer 1998; 82:2145-2149.
7. Sorensen HT, Friis S, Olsen JH, Thulstrup AM, Mellemkjaer L, Linet M, et al. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. Hepatology 1998; 28:921-925.
8. Donato F, Gelatti U, Tagger A, Favret M, Ribero ML, Callea F, et al. Intrahepatic cholangiocarcinoma and hepatitis C and B virus infection, alcohol intake, and hepatolithiasis: a case-control study in Italy. Cancer Causes Control 2001; 12:959-964.
9. Suriawinata A, Ivanov K, Ben Haim M, Schwartz ME. A 67-year old man with hepatitis C virus infection and a liver tumor. Semin Liver Dis 2000; 20:227-231.
10. Tanaka T, Imamura A, Hayashi S, Tsuruta K, Igari T, Koike M, et al. Minute mixed hepatoma with two components: hepatocellular and cholangiocarcinoma, which developed on liver cirrhosis with HCV. Hepatogastroenterology 1998; 45:220-223.
11. Nagano K, Fukuda Y, Nakano I, Katano Y, Toyoda H, Ebata M, et al. A case of the development of two hepatocellular carcinomas and a cholangiocarcinoma with cirrhosis after elimination of serum hepatitis C virus RNA with interferon therapy. Hepatogastroenterology 2000; 47:1436-1438.
12. Taguchi J, Nakashima O, Tanaka M, Hisaka T, Takazawa T, Kojiro M. A clinicopathological study on combined hepatocellular and cholangiocarcinoma. J Gastroenterol Hepatol 1996; 11:758-764.
13. Kaczynski J, Hansson G, Wallerstedt S. Incidence, etiologic aspects and clinicopathologic features in intrahepatic cholangiocellular carcinoma - a study of 51 cases from a low-endemicity area. Acta Oncol 1998; 37: 77-83.
14. Songsivilai S, Dharakul T, Kanistanon D. Hepatitis C virus genotypes in patients with hepatocellular carcinoma and cholangiocarcinoma in Thailand. Trans R Soc Trop Med Hyg 1996; 90:505-507.
15. Tangkijvanich P, Theamboonlers A, Hirsch P, Thongngam D, Kullavanijaya P, Poovorawan Y. Hepatitis viruses and chronic liver disease. Southeast Asian J Trop Med Public Health 1999; 30:489-495.
16. Uchida T, Shikata T, Tanaka E, Kiyosawa K. Immunoperoxidase staining of hepatitis C virus in formalin-fixed, paraffin-embedded needle liver biopsies. Virchows Arch 1994; 424:465-469.
17. Liu XF, Zou SQ, Qiu FZ. Construction of HCV-core gene vector and its expression in cholangiocarcinoma. World J Gastroenterol 2002; 8:135-138.
18. Gores GJ. Early detection and treatment of cholangiocarcinoma. Liver Transpl 2000; 6 (suppl 2):30-34.
19. Patel AH, Harnois DM, Klee GG, LaRusso NF, Gores GJ. The utility of CA 19-9 in the diagnosis of cholangiocarcinoma in patients without primary sclerosing cholangitis. Am J Gastroenterol 2000; 95:204-207.
20. Loyer EM, Chin H, DuBrow RA, David CL, Eftekhari F, Charnsangavej C. Hepatocellular carcinoma and intrahepatic peripheral cholangiocarcinoma: enhancement patterns with quadruple phase helical CT - a comparative study. Radiology 1999; 213:866-875.
21. Lacomis JM, Baron RL, Oliver JH, Nalesnik MA, Federle MP. Cholangiocarcinoma: delayed CT contrast enhancement patterns. Radiology 1997; 203:98-104.
22. Valls C, Guma A, Puig I, Sanchez A, Andia E, Serrano T, et al. Intrahepatic peripheral cholangiocarcinoma: CT evaluation. Abdom Imaging 2000; 25:490-496.
23. Zignego A, Ferri C, Giannini C, La Civita L, Careccia G, Longombardo G, et al. Hepatitis C virus infection in mixed cryoglobulinemia and B-cell non-Hodgkin's lymphoma: evidence for a pathogenetic role. Arch Virol 1997; 142:545-555.
24. Rasul L, Shepherd F, Kamel-Reid S, Krajden M, Pantolony D, Heathcote JE. Detection of occult low-grade B-cell non-Hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. Hepatology 1999; 29:543-547.